1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Chongqing Porton Fine Chemicals Co., Ltd.

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2005

Location

Chongqing China

Primary Industry

Pharmaceuticals

About

Established in 2005 and based in Chongqing, China, Chongqing Porton Fine Chemicals Co., Ltd. operates as a pharmaceutical custom R&D and production service provider. The company listed on the Shenzhen stock exchange in January 2014 and the stock code is 300363. The company provides pharmaceutical intermediates R&D and production services for patients with AIDS, anti-hepatitis C and hypolipidemic. The company also provides customized pharmaceutical R&D and production services for biopharmaceutical company. The company focuses on innovative drugs from clinical trials to patent drug sales.
Current Investors
Huatai Securities, Chongqing Liangjiang New Area Development and Investment Group, Huatai Ruilian Fund Management

Request a demo to show more

Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
http://www.porton.cn
Verticals
HealthTech, Manufacturing
Company Stage
Mature
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.